Shenzhen Chipscreen Biosciences Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003LW0
CNY
31.30
-0.75 (-2.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
907.51
655.76
515.79
527.89
428.61
267.88
171.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
907.51
655.76
515.79
527.89
428.61
267.88
171.94
Raw Material Cost
142.51
112.01
82.24
52.76
34.25
19.92
10.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
219.95
213.87
182.36
189.94
102.68
86.71
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
35.84
34.37
35.03
20.26
4.86
1.13
1.54
Selling and Distribution Expenses
464.98
397.38
359.62
306.61
281.62
158.82
104.75
Other Expenses
17.32
-5.36
0.89
-4.71
-7.02
-1.25
-3.73
Total Expenditure (Excl Depreciation)
816.54
710.16
699.65
514.87
440.48
270.08
166.12
Operating Profit (PBDIT) excl Other Income
91
-54.400000000000006
-183.9
13
-11.899999999999999
-2.2
5.8
Other Income
29.56
111.53
324.85
28.94
36.42
38.65
16.86
Operating Profit (PBDIT)
184.81
112.42
186.60
77.22
44.65
47.30
27.34
Interest
35.84
34.37
35.03
20.26
4.86
1.13
1.54
Exceptional Items
0.24
-89.96
0.84
0.82
0.08
1.80
0.02
Gross Profit (PBDT)
765.00
543.76
433.55
475.13
394.35
247.96
161.50
Depreciation
72.89
61.50
45.62
42.46
21.27
11.80
5.09
Profit Before Tax
76.32
-73.40
106.79
15.32
18.60
36.17
20.73
Tax
-0.91
17.86
47.83
2.34
-3.36
5.12
1.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.96
-114.57
88.84
17.48
21.96
31.05
19.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.96
-114.57
88.84
17.48
21.96
31.05
19.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-39.65
-4.67
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.96
-114.57
49.19
12.82
21.96
31.05
19.42
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,502.13
1,457.33
1,586.13
1,391.67
1,417.61
1,566.19
1,446.33
Earnings per share (EPS)
0.13
-0.28
0.22
0.04
0.05
0.08
0.05
Diluted Earnings per share
0.13
-0.28
0.22
0.04
0.05
0.08
0.05
Operating Profit Margin (Excl OI)
9.08%
-9.24%
-35.65%
1.1%
-3.04%
-1.17%
3.13%
Gross Profit Margin
16.44%
-1.82%
29.55%
10.95%
9.3%
17.91%
15.02%
PAT Margin
5.62%
-17.47%
17.22%
3.31%
5.12%
11.59%
11.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 38.38% vs 27.14% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 144.50% vs -332.93% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 17,155.56% vs 100.65% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 4.07% vs -1.71% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Shenzhen Chipscreen Biosciences Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
907.51
0
907.51
Other Operating Income
0.00
0.00
0.00
Total Operating income
907.51
0
907.51
Raw Material Cost
142.51
0
142.51
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
35.84
0
35.84
Selling and Distribution Expenses
464.98
0
464.98
Other Expenses
17.32
0.00
17.32
Total Expenditure (Excl Depreciation)
816.54
0
816.54
Operating Profit (PBDIT) excl Other Income
90.97
0.00
90.97
Other Income
29.56
0
29.56
Operating Profit (PBDIT)
184.81
0
184.81
Interest
35.84
0
35.84
Exceptional Items
0.24
0
0.24
Gross Profit (PBDT)
765.00
0
765.00
Depreciation
72.89
0
72.89
Profit Before Tax
76.32
0
76.32
Tax
-0.91
0
-0.91
Provisions and contingencies
0
0
0.00
Profit After Tax
50.96
0
50.96
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
50.96
0
50.96
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.96
0
50.96
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,502.13
0
1,502.13
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
9.08%
0%
0.00
9.08%
Gross Profit Margin
16.44%
0%
0.00
16.44%
PAT Margin
5.62%
0%
0.00
5.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 90.75 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 38.38% vs 27.14% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 5.10 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 144.50% vs -332.93% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.53 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 17,155.56% vs 100.65% in Dec 2024

Annual - Interest
Interest 3.58 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 4.07% vs -1.71% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.08%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024